Bivalent AMPA receptor positive allosteric modulators

US9328125B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9328125-B2
Application numberUS-201414474258-A
CountryUS
Kind codeB2
Filing dateSep 1, 2014
Priority dateMar 1, 2012
Publication dateMay 3, 2016
Grant dateMay 3, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the invention are directed to compounds that are positive allosteric modulators of AMPA receptors.

First claim

Opening claim text (preview).

The invention claimed is: 1. A positive allosteric modulator of AMPA receptors (AMPAR) having a general formula of Formula I: where R 1 and R 2 are independently hydrogen, C 1 -C 6 alkyl or C 1 -C 6 heteroalkyl; and R 3 is hydrogen, nitro, amine, cyano, substituted or unsubstituted sulfonyl, substituted or unsubstituted acyl, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl, or a substituted or unsubstituted heteroaryl; and n is 0; and L is —C(O)—; X is a indole, indazole, or pyridine. 2. The positive allosteric modulator of claim 1 , wherein R 1 and R 2 are independently C 1 -C 6 alkyl. 3. The positive allosteric modulator of claim 1 , wherein R 1 is methyl or isopropyl. 4. The positive allosteric modulator of claim 1 , wherein R 2 is methyl. 5. The positive allosteric modulator of claim 1 , wherein X is pyridine. 6. The positive allosteric modulator of claim 1 , wherein R 3 is substituted or unsubstituted N-containing C 5 -C 6 heterocyclyl. 7. The positive allosteric modulator of claim 1 , wherein the modulator is selected from Propane-2-sulfonic acid (2-{4-[2-(pyrrolidine-1-carbonyl)-pyridin-4-yl]-phenyl}-propyl)-amide (HJC-1-22); Propane-2-sulfonic acid (2-{4-[5-(piperidine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-1-24); Propane-2-sulfonic acid (2-{4-[5-(piperidine-1-carbonyl)-pyridin-2-yl]-phenyl}-propyl)-amide (HJC-1-59); Propane-2-sulfonic acid (2-{4-[5-(piperidine-1-carbonyl)-indazol-1-yl]-phenyl}-propyl)-amide (HJC-2-8); Propane-2-sulfonic acid (2-{4-[5-(pyrrolidine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-2-10); Propane-2-sulfonic acid (2-{4-[5-(4-methyl-piperazine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-2-22); Propane-2-sulfonic acid (2-{4-[5-(piperazine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-2-37); Propane-2-sulfonic acid (2-{4-[5-(4-methanesulfonyl-piperazine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-2-67); Propane-2-sulfonic acid (2-{4-[5-(4-acetyl-piperazine-1-carbonyl)-indol-1-yl]-phenyl}-propyl)amide (HJC-2-68); Propane-2-sulfonic acid (2-{4-[2-(piperidine-1-carbonyl)-pyridin-4-yl]-phenyl}-propyl)-amide (HJC-2-69); or Propane-2-sulfonic acid (2-{4-[5-(pyrrolidine-1-carbonyl)-pyridin-2-yl]-phenyl}-propyl)-amide (HJC-2-70). 8. The positive allosteric modulator of claim 1 , wherein the modulator is Propane-2-sulfonic acid (2-{4-[2-(pyrrolidine-1-carbonyl)-pyridin-4-yl]-phenyl}-propyl)-amide (HJC-1-22).

Assignees

Inventors

Classifications

  • Ortho-condensed systems · CPC title

  • with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title

  • Benzopyrazoles; Hydrogenated benzopyrazoles · CPC title

  • C07F5/025Primary

    Boronic and borinic acid compounds · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9328125B2 cover?
Embodiments of the invention are directed to compounds that are positive allosteric modulators of AMPA receptors.
Who is the assignee on this patent?
Zhou Jia, Chen Haijun, Johnson Kenneth M, and 2 more
What technology area does this patent fall under?
Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).